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 Twenty percent of the total number of human leukocytes is lymphocytes. 
Lymphocytes are responsible for the control of the adaptive immune system. 
Physical activity is any body movement that requires energy to do it. 
Physical activity is related to changes in a person's immunity so that it can 
reduce the risks of diseases such as obesity, hypertension, diabetes, cancer, 
and stroke. Black Cumin Seed Oil (BCSO) in various studies has been 
widely used as a supplement, especially as an immune-modulator.  
The purpose of this study is to see the effect of physical activity  
on lymphocyte levels in smokers who have been given Black Cumin Seed 
Oil for 30 days. This study used a single-blind Randomized Controlled Trial 
(RCT) method, with a total of 36 test subjects divided into four groups. 
Group 1 received placebo 3x1 capsules/day, group 2 received BCSO  
3x1 capsules/day, group 3 received BCSO 3x2 capsules/day, and group  
4 received BCSO 3x3 capsules/day. The intervention was carried out for  
30 days, then on the 31st-day blood was drawn for analysis. Data analysis 
using an independent t-test to see the average group with high and low 
activity, while to see the average lymphocyte between treatment groups using 
one way ANOVA test. The test results were said to be significant if p <0.05. 
The p-value of the independent t-test is 0.045, and one way ANOVA test  
p-value is 0.343. In conclusion, physical activity can increase lymphocyte 
levels significantly, but not on BCSO administration. 
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1. INTRODUCTION  
Smoking is associated with many diseases throughout the world [1]. It has been reported that about 
1/3 of the adult population are smokers [2]. Cigarette smoke contains many harmful chemicals such  
as carbon monoxide, nicotine, tar, nitrogen oxides, and cadmium [3, 4]. Smoking dramatically influences  
the body's immune production and inflammatory mediators, both proinflammatory  
and anti-inflammatory cytokines [5]. The impact of tobacco could affect innate and adaptive immunity.  
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Adaptive immune cells that are affected by smoking are T cells (Th1 / Th2 / Th17), CD4 +, CD25 +, 
regulatory T cells, CD8 + T cells, memory T cells, B cells, whereas innate immune cells that are affected  
by smoking are DC, macrophages, and NK cells [6]. Cigarettes have to cause diseases such as cancer  
(lung cancer, bladder cancer, breast cancer), pregnancy (preterm birth, low birth weight, placenta previa), 
autoimmune disease (rheumatoid arthritis, chronic obstructive pulmonary disease, lupus erythematosus 
system), neurological disease (Alzheimer's disease, stroke, Parkinson's disease), graft rejection 
(cardiovascular graft, renal graft, lung transplants), oral and respiratory conditions (asthma, chronic 
obstructive pulmonary disease, hypersensitivity pneumonitis), cardiovascular diseases (myocardial infarction, 
cardiac arrhythmia) [7, 8]. The molecular pathway affected by smoking involves NFκB, MAP kinase,  
and histone modification [9]. Some epidemiological data show that smoking and smoke exposure are 
associated with polycythemia [10, 11]. The condition of polycythemia in smokers is an adaptation 
mechanism to maintain homeostasis due to the reduced amount of partial pressure of O2  
in the arteries [11, 12]. 
Lymphocytes are part of leukocytes [13]. Lymphocytes are the main component of the body's 
immune system consisting of T lymphocytes, B lymphocytes, and NK cells. Lymphocytes are the main body 
defense agents that work against infection through the phagocytosis process. Lymphocytes also play a role  
in the immune response against damage caused by smoking. These cells are responsible for producing 
antibodies, killing cells infected with viruses and tumor cells directly, and regulating the immune  
response [12, 14]. The number of lymphocytes is influenced by various conditions, including infection, 
malignancy, exercises and toxic agents [15]. 
Physical activity is the movement of the body produced by skeletal muscle that requires energy 
expenditure [16]. Physical activity has linked to improved immune status and fitness levels [17].  
The duration and intensity of physical activity affect blood parameters. Regular physical activity reduces free 
radicals that are formed in the body after continuous smoking [18]. Physical activity can also improve bone 
and functional health so that when physical activity decreases, it can weaken the immune system and can 
cause various diseases and death. Physical and physiological responses also play an essential role  
in hematology [19, 20]. However, excessive physical activity has a negative effect, namely causing oxidative 
stress damage [21]. 
Black cumin seed oil (Nigella sativa L.) is a medicinal plant that is widely used throughout  
the world [22]. Black cumin has been commonly used in the treatment of various diseases,  
including anticancer, hepatoprotective, antimicrobial, analgesic, antidiabetic, anti-inflammatory, 
immunomodulatory, a bronchodilator, antihypertensive, spasmolytic, and antioxidant [22-25]. Black cumin 
with the main active ingredient thymoquinone has been reported to have the ability to modulate 
inflammation, cellular and humoral adaptive immune responses, and the Th1/ Th2 paradigm [26, 27].  
Black cumin is also said to be able to increase NK cell cytotoxic activity. Te molecular and cellular 
mechanisms which underlie the immunomodulatory and anti-inflammatory effects are widely  
investigated [28]. Until now, how the impact of BCSO consumption on the number of lymphocytes in 
smokers has not been studied. Based on this description, this study was conducted to determine how the 
effect of physical activity on lymphocyte levels in healthy volunteers, who are active smokers who have been 
administered BCSO for 30 days with different doses. 
 
 
2. RESEARCH METHOD  
2.1 Type and design of the study 
This research is an experimental study with a Randomized Controlled Trial (RCT) design.  
The independent variable in this study is BCSO, while the dependent variable is the level of lymphocytes. 
Physical activity is identified as a confounding variable. This research was conducted in the working area of 
the Bantul Jetis I Public Health Center (PHC), in Yogyakarta, in September 2019 to October 2019. 
Researchers applied the principles of good clinical practice for testing in humans, according to the Helsinki 
declaration [29]. 
 
2.2.  Research subject and intervention 
The population in this study was healthy adult males and smokers. The affordable populations 
include healthy volunteers, are active smokers, and are in the working area of the Jetis I Primary Health 
Center (PHC) in Bantul, Yogyakarta. The sampling technique used is purposive sampling, where researchers 
determine the sample based on predetermined criteria. The Republic of Indonesia Food and Drug 
Examination Agency has issued a guide on the number of subjects for phase 1 clinical trials, amounting  
to between 20-50 volunteers [30]. The inclusion criteria in this study were healthy adult males,  
aged >18 years, active smokers, and willing to participate in the study by filling out and signing informed 
consent. The subjects candidates that have been selected through inclusion criteria will be excluded from  
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the study subject if the subject has a history of chronic illness, experiences allergic reactions after 
administration of BCSO, mental illness, test subjects who did not take part in the study until the end,  
and were not willing to be present during blood draws on day-to-day 31. Eligible subjects were divided into 
four groups by simple random sampling. Subjects received a BCSO capsule with three dose ratings  
or a 3x1 placebo for 30 days. Reviewing health conditions and side effects is done every day through  
the smartphone. Every three days, home visits are carried out to count the remaining drugs and measure  
vital signs. 
 
2.3.  Tools and materials 
The tools and the materials used in this study include primary and secondary data collection sheets 
using a case report form (CRF), blood collection equipment, and a set of tools for blood analysis.  
Physical activity data collection was carried out with a universal physical activity questionnaire. Case Report 
Form (CRF) was used to collect demographic and lifestyle data. While lymphocyte levels were analyzed 
using Hematology Analyzer.  Measurement of vital signs, filling of case report forms (CRF), and nutritional 
status and blood collection were carried out at the citizen's house. Complete blood measurements were 
performed at Nur Hidayah Hospital. 
 
2.4.  Variables of research and operational definitions 
The independent variables are BCSO and physical activity, while the dependent variable  
is lymphocytes. BCSO is available in capsules with a given dosage level of 3x1 capsules/day,  
3x2 capsules/day, and 3x3 capsules/day, then compared to the control group who received placebo  
3x1 capsules/day. The physical activities in this study were grouped into two, namely low and high physical 
activity. In general, data collection in this study was conducted by interview, observation, and direct 
measurement. Primary and secondary data in the form of patient identity, smoking habits, history of illness, 
current medical history, and physical activity were collected by structured interviews with questionnaires that 
were guided and carried out directly in each resident's home. 
 
2.5.  Research procedure 
The instrument used in this study is the case report form (CRF), which is used to obtain primary and 
secondary data in the form of patient identity, smoking habits, history of illness, current medical history, 
physical activity, and others. The implementation phase of activities in the field are as follow:  
(i) The collection of the candidate's subjects test (ii) The candidates subject test who meet the inclusion 
criteria have explained the research objectives and asked to fill out information sheets as proof  
of participant's participation in the study. (iii) The subjects who are willing to volunteer are asked to measure 
their blood pressure, pulse, body temperature, abdominal circumference, weight, and height for  
the determination of body mass index. (iv) CRF filling is carried out every 2x monitoring in one week for one 
month to obtain primary and secondary data. (v) The 31st day the subjects were gathered for blood draws. 
(vi) Blood that has been taken is then performed a complete blood examination at Nur Hidayah Hospital with 
a hematology analyzer. 
 
2.6.  Data analysis 
The analysis used to compare the average of lymphocytes between groups is one-way ANOVA, 
while the analysis to compare the average of lymphocytes in subjects with low and high physical activity  
is using the independent t-test. 
 
2.7.  Research ethics 
Since this study involves human respondents, it is essential to explain to all prospective respondents 
about the aims and objectives of the study, the expected benefits and uses, and the consequences  
of the respondent (informed consent), in addition to the management of ethical permits  
(166/EP-FKIK-UMY/V/2019). 
 
 
3. RESULTS AND DISCUSSION  
3.1.  Overview of respondents 
The subject of this study consists of 36 active smokers divided into four treatment groups who are 
the residents in the work area of the Jetis 1 Public Health Center in Bantul. The demographic conditions  
of the study subjects according to gender, education, marital status, occupation, smoking status, age,  
duration of smoking, the amount of cigarette consumption, lymphocytes, and physical activity are presented 
in Table 1. 
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Table 1. Demographic characteristics of respondents 
No Respondents characteristics Percentage (%) Average ± SD Total 
1 Sex 
Male 100%  
36 (100%) 
Female 0%  
2 Education 
Primary School 11.1%  
36 (100%) 
Junior High School 16.7%  
Senior High School 58.3%  
S1/S2/S3 13.9%  
3 Marital Status 
Married 66.7%  
36 (100%) 
Not Married 33.3%  
4 Occupation 
PNS 2.8%  
36 (100%) 
Swasta Nasional 13.9%  
Small self-employed 16.7%  
Farmer 2.8%  
Laborer 47.2%  
e.t.c 16.7%  
5 Smoking Status Smoking 100%  
36 (100%) 
  Not smoking 0%  
6 Age   38.69 ± 11.659  
7 Length of smoking (year)   20.92 ± 10.808  
8 Cigarette Consuming total (stick/day)   10.61 ± 7.680  
9 Lymphocytes (%)   35.16 ± 9.51  
10 Physical Activity  (MET/week)   2924.64 ± 624.575  
MET/week: Metabolic Equivalent/week 
 
 
Table 1 shows the characteristics of the respondents used as the test subjects. The gender of the test 
subjects is male with a percentage (100%), the education level is mostly high school graduates (58.3%),  
most of them are married (66.7%), and the work is dominated by laborers (47.2%). All of the test subjects are 
smokers (100%). The average age of the test subjects was 38.69 years, the average length of smoking was 
20.92 years, the average number of cigarette consumption was 10.61 cigarettes/day, the average lymphocyte 
level was 35.16%, and the average physical activity is 2924.64 Metabolic Equivalent/week (MET/week). 
 
3.2.  Analysis of lymphocyte levels between treatment groups 
The number of lymphocytes in healthy volunteer smokers who administered BCSO is presented  
in Table 2. The average lymphocyte after giving placebo and BCSO for 30 days were the placebo group 
 at 36.58%, the BCSO group 3x1 by 38.77%, the BCSO group 3x2 by 34.53%, and the BCSO group 3x3  
by 30.54%. Cigarettes can increase lymphocyte levels according to previous studies [12-14]. Table 3 shows 
the BCSO dose of 3x3 capsules/day has the best average lymphocyte, followed by a dose of 3x2 capsules/day 
and a dose of 3x1 capsules/day. BCSO has been shown to reduce high lymphocyte levels caused by smoking. 
The average levels of lymphocytes that have been obtained are then analyzed with the one way 
ANOVA test, which has previously fulfilled normality and homogeneity tests to see whether there are 
significant differences between the groups. Based on the results of the one way ANOVA test in Table 4,  
the p-value is 0.343>0.05 which means that there is no significant difference between the average levels of 
lymphocytes in the placebo group, BCSO 3x1 capsules/day, BCSO 3x2 capsules/day, and BCSO  
3x3 capsules/day. A lymphocyte is the type of white blood cell that is also part of the body's defense system. 
Normal lymphocyte levels can help prevent and fight various infections; the average value of lymphocytes  
in the blood is 20-35%. Lymphocyte levels can be influenced by several things, namely physical activity, 
bacterial and fungal infections, poor nutritional status, excessive stress, and congenital disabilities. 
 
 
Table 2. The average lymphocyte number of healthy smoker BCSO administration for 30 days 
Group n Lymphocyte average (%) Standard Deviation Sig – (2-tailed) 
Placebo 3x1 capsules/day (control) 8 36.58 7.36 
0.343 
BCSO 3x1 capsule/day 9 38.77 9.72 
BCSO 3x2 capsule/day 11 34.53 9.74 
BCSO 3x3 capsule/day 8 30.54 10.50 
Total 36 35.16 9.51  
 The analysis of bivariate using one-way ANOVA  
 If p<0.05 there was a significant difference 
 
3.3.  Analysis of lymphocyte levels between a group of physical activity 
The physical activities in this study are grouped into two, namely low and high physical activity, 
where the average physical activity becomes a cut point. The average physical activity of the test subjects  
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is 2924.64 MET/week. If it is less than the average, it is classified as low activity, whereas if it is more than 
average, it is classified as the high activity. 
 
 
Table 3. Independent t-test for lymphocyte levels between the groups of low physical activity and high 
physical activity. 
Physical Activity n Lymphocytes average (%) ± SD Sig. (2-tailed) 
Activity (-) 21 32.4905 ± 9.47 
0.045* 
Activity (+) 15 38.89 ± 8.51 
 *it has a significant difference because p<0.05 
 Activity (-) = low physical activity <2924.64 
 Activity (+) = high physical activity >2924.64 
 
 
The test subjects with low activity were found with several 21 people and 15 people with high 
physical activity. The average lymphocyte with low activity was 32.49%, and the average lymphocyte with 
high activity was 38.89%. The analysis used to compare lymphocyte levels in the low physical activity group 
with the high activity group is the independent t-test where there is a significant difference if p <0.05.  
The independent t-test shows the value of sig. (2-tailed) which is equal to 0.045, which means there  
is a significant difference between lymphocyte levels in the low physical activity group and high activity 
group. These results indicate that the increase in lymphocytes along with the high physical activity. 
 
3.4. Analysis of lymphocyte levels between treatment groups and physical activity 
Table 4 presents lymphocyte counts based on physical activity in healthy smokers volunteer.  
The physical activity can increase lymphocyte levels can be seen in Table 4. The average lymphocytes  
at high activity are more than the average lymphocytes at low activity, but after being analyzed  
by independent t-test, significant differences were only found in the control group, meaning that the mean od 
Lymphocytes with high activity are higher than those with low activity without being affected by giving  
the BCSO. The average lymphocytes in the BCSO group both 3x1, 3x2, and 3x3 doses with high and low 
activity there were no statistically significant differences. 
 
 
Table 4. The average lymphocyte levels of each group with high and low physical activity of the healthy 
smoker who administered BCSO. 
Group High Physical activity + Low Physical activity - Sig (2-tailed) 
Placebo 3x1 capsule/day (control) 42.700 ± 6.532 23.400 ± 4.938 0.046
a
* 
BCSO 3x1 capsule/day 38.960 ± 5.842 31.350 ± 5.333 0.720
a
 
BCSO 3x2 capsule/day 39.700 ± 6.532 31.571 ±4.938 0.197a 
BCSO 3x3 capsule/day 33.260 ± 5.842 18.233 ± 5.333 0.433a 
Sig (2-tailed) 0.563
b
 0.466
b
  
 an independent analysis t-test, there is a significant difference if p <0.05 
 
b 
one-way ANOVA analysis, there is a significant difference if p <0.05 
 * there is a significant difference p <0.05 
 
 
The results of the one way ANOVA analysis were used to see the difference in the average 
lymphocytes of the four treatment groups at both high and low activities. The p-value for high physical 
activity is 0.563, and for low activity is 0.466, the p-value is higher than 0.05, so there is no statistically 
significant difference between lymphocyte levels in each treatment group. Clinically, it can be seen that  
the higher BCSO dose, the average lymphocyte decreases, this shows BCSO with a dose of 3x3 capsules/day 
can reduce lymphocyte levels which increase due to cigarette consumption and physical activity  
to the normal range of 33,260%, while in low physical activity by giving BCSO 3x3, it reduces lymphocyte 
levels to below the normal range of 18,233%, so it needs to be adjusted between the amount of cigarette 
consumption, physical activity and dosage of BCSO, so that lymphocyte levels are in the normal range.  
The results of the study are in accordance with previous studies that BCSO is tolerated and safe  
for consumption [31]. 
 
 
4. CONCLUSION  
The increasing of the lymphocyte levels are associated with a person's smoking condition and 
excessive physical activity, but by giving BCSO, it can reduce the high lymphocyte levels due to extreme 
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physical activity and smoking conditions. The higher the physical activity, the higher the level of a person's 
lymphocytes as well as the consumption of cigarettes. The higher the BCSO dose, the lymphocyte levels 
decrease in smokers, so it needs to be adjusted between the amount of cigarette consumption,  
physical activity, and the treatment of BCSO so that the lymphocyte levels are in the normal range.  
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